1-20 of 527
time-to-treatment
Close
Save search
Sort by
Journal Articles

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Free
Clinical Trials & Observations
Christoph Röllig, Michael Kramer, Christoph Schliemann, Jan-Henrik Mikesch, Björn Steffen, Alwin Krämer, Richard Noppeney, Kerstin Schäfer-Eckart, Stefan W. Krause, Mathias Hänel, Regina Herbst, Volker Kunzmann, Hermann Einsele, Edgar Jost, Tim H. Brümmendorf, Sebastian Scholl, Andreas Hochhaus, Andreas Neubauer, Kristina Sohlbach, Lars Fransecky, Martin Kaufmann, Dirk Niemann, Markus Schaich, Norbert Frickhofen, Alexander Kiani, Frank Heits, Ulrich Krümpelmann, Ulrich Kaiser, Johannes Kullmer, Maxi Wass, Friedrich Stölzel, Malte von Bonin, Jan Moritz Middeke, Christian Thiede, Johannes Schetelig, Wolfgang E. Berdel, Gerhard Ehninger, Claudia D. Baldus, Carsten Müller-Tidow, Uwe Platzbecker, Hubert Serve, Martin Bornhäuser
Journal: Blood
Blood (2020) 136 (7): 823–830.
https://doi.org/10.1182/blood.2019004583
Published: 2020
Includes: Supplemental data
Journal Articles

The Impact of Diagnosis to Treatment Interval on the Outcome of Patients with Acute Myeloid Leukemia

Free
Samah Nassereddine, MD, Kimberley Doucette, MD MSc, Vanya Aggarwal, Richard Amdur, PhD, Imad A. Tabbara, MD, Catherine E. Lai, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2212.
https://doi.org/10.1182/blood-2019-124150
Published: 2019
Journal Articles

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Free
Sæmundur Rögnvaldsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5444.
https://doi.org/10.1182/blood-2019-131514
Published: 2019
Journal Articles

An Analysis from the WM UK Rory Morrison Registry - How Does Waldenström's Macroglobulinemia Affect Younger Patients?

Free
Oliver Tomkins, BMBS, MRCP, Joshua Bomsztyk, Helen McCarthy, MBBS, PhD, Jaimal Kothari, Dima El-Sharkawi, Charalampia Kyriakou, Guy Pratt, Ali Rismani, MBBS, Shirley D'Sa
Journal: Blood
Blood (2019) 134 (Supplement_1): 1543.
https://doi.org/10.1182/blood-2019-123693
Published: 2019
Journal Articles

Outcomes for Double Hit Lymphoma Patients Identified Via Routine Vs Selective Testing for MYC Rearrangement

Free
Zachary AK Frosch, MD, Sunita Dwivedy Nasta, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Stefan K. Barta, MD MRCP, MS, James N. Gerson, MD, Elise A. Chong, MD, Emily C. Ayers, MD, Joanna M Rhodes, MD, Alexa Koike, Jennifer J.D. Morrissette, PhD, Daniel J. Landsburg, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1607.
https://doi.org/10.1182/blood-2019-125944
Published: 2019
Journal Articles

Risk Factors for Increased Length of Stay (LOS) in Patients with Hematological Malignancies Electively Admitted for Chemotherapy

Free
Christopher E. Wee, MD, Jilan Kubusek, PharmD, Irbaz Riaz, MDMMSc, Robert Wolf, PharmD, RPh, Julian R Molina, MD PhD, Naseema Gangat, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2138.
https://doi.org/10.1182/blood-2019-127367
Published: 2019
Journal Articles

The 'Real World' Uptake and Prognostic Impact of GELF in Newly Diagnosed Follicular Lymphoma: An Australasian Alliance Initiative

Free
Allison Barraclough, Edward Yoo, Chan Y. Cheah, Dipti Talaulikar, Bianca Nguyen, Michelle Turner, Fatima Tahir, Jing Huang, Colm Keane, MD, Mitchel Lincoln, Tara Cochrane, Anna M. Johnston, Michael Dickinson, MBBS,FRACP,FRCPA, Stephen Opat, Zoe McQuilten, Erica M. Wood, Gayathri St George, Cameron Wellard, Eliza A Hawkes
Journal: Blood
Blood (2019) 134 (Supplement_1): 3986.
https://doi.org/10.1182/blood-2019-129294
Published: 2019
Journal Articles

Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma

Free
Narendranath Epperla, MDMS, Jeffrey M. Switchenko, PhD MS, Krithika Shanmugasundaram, MD, Subir Goyal, Oscar Calzada, BS, Michael C. Churnetski, Bhaskar Kolla, MBBS, Veronika Bachanova, MD PhD, James N. Gerson, MD, Stefan K. Barta, MD MRCP, MS, Max J. Gordon, MD, Alexey Danilov, MD PhD, Natalie S Grover, MD, Stephanie Mathews, MD, Madelyn Burkart, MD, Reem Karmali, MD, Yazeed Sawalha, MD, Brian T. Hill, MD, Nilanjan Ghosh, MD PhD, Steven I Park, MD, David A. Bond, MD, Talha Badar, MD, Kristie A. Blum, MD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Mary-Kate Malecek, MD, Peter Martin, FRCPC, MD MS, Jin Guo, MD, Brad S. Kahl, MD, Christopher R. Flowers, MD MS, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3997.
https://doi.org/10.1182/blood-2019-128632
Published: 2019
Journal Articles

Analysis of a Safety Run-in Cohort from Niveau, a Phase 3 Study for Patients with Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivolumab in Combination with Gemcitabine, Oxaliplatin (GemOx) Plus Rituximab (R) in Case of B-Cell Lymphoma

Free
Gerhard Held, MD, Corinne Haioun, MD PhD, Roch Houot, MD PhD, Philippe Gaulard, MD PhD, Thierry Molina, Andreas Rosenwald, MD, Marc André, Joerg Hoffmann, MD, Martin Dreyling, MD, Olivier Casasnovas, MD, Herve Maisonneuve, MD, Herve Tilly, MD PhD, Thomas Illmer, Stephanie Mayer, MD, Heinz Kirchen, MD, Paul La Rosée, MD, Markus Loeffler, MD, Marita Ziepert, PhD, Bettina Altmann, PhD, Viola Poeschel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4085.
https://doi.org/10.1182/blood-2019-129347
Published: 2019
Journal Articles

Utilization of Immune Checkpoint Inhibitors for Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) in Oncology Community Practices

Free
Ajeet Gajra, MD FACP, Andrew J Klink, PhD MPH, Chadi Nabhan, MDMBA, FACP, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 4057.
https://doi.org/10.1182/blood-2019-129632
Published: 2019
Journal Articles

An Analysis from the WM UK Rory Morrison Registry: Waldenström's Macroglobulinaemia Patient Demographics, Disease Characteristics and Evolving Treatment Choices

Free
Oliver Tomkins, BMBS, MRCP, Joshua Bomsztyk, Helen McCarthy, MBBS, PhD, Jaimal Kothari, Dima El-Sharkawi, Charalampia Kyriakou, Guy Pratt, Ali Rismani, MBBS, Shirley D'Sa
Journal: Blood
Blood (2019) 134 (Supplement_1): 4016.
https://doi.org/10.1182/blood-2019-129212
Published: 2019
Journal Articles

Report on the Treatment of Hodgkin Lymphoma with ABVD Chemotherapy at Two Rural District Hospitals in Rwanda

Free
Cyprien Shyirambere, MD, Rebecca Deboer, MD, Yvan Butera, MD, Caitlin Driscoll, resident, Jean Bosco Bigirimana, Francois Regis Uwizeye, Temidayo Fadelu, MD, Paul H Park, MD, Alan Paciorek, Leslie E. Lehmann, MD, Lawrence N. Shulman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4053.
https://doi.org/10.1182/blood-2019-130780
Published: 2019
Journal Articles

Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies

Free
Grzegorz Nowakowski, MD, Annalisa Chiappella, Fangxin Hong, PhD, Randy D. Gascoyne, MD, David W. Scott, MBChB, PhD, William R. Macon, MD, Rebecca L. King, MD, Jennifer E. Amengual, MD, Richard F. Little, MD MPH, John P. Leonard, MD, Jonathan W. Friedberg, MD, Lale Kostakoglu, MD MPH, Wojciech Jurczak, Kazuhito Yamamoto, Myron Czuczman, Jacqueline Russo, Krista Hudak, PharmD, Jingshan Zhang, PhD, Steve Wade, Thomas E. Witzig, MD, Brad S. Kahl, MD, Umberto Vitolo
Journal: Blood
Blood (2019) 134 (Supplement_1): 4092.
https://doi.org/10.1182/blood-2019-123083
Published: 2019
Journal Articles

Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-Versus-Host Disease with Prednisone and Everolimus (PredEver first): A Prospective Multicenter Phase IIa Study

Free
Francis Ayuketang Ayuk, MD, Eva Maria Wagner, MD, Daniel Wolff, MD, Stephanie von Harsdorf, MD, Christian Koenecke, MD, Herbert G. Sayer, MD PhD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4523.
https://doi.org/10.1182/blood-2019-129801
Published: 2019
Journal Articles

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

Free
Rachael E Hough, MD, Amy A Kirkwood, Sujith Samarasinghe, Clare J Rowntree, MBBS, PhD FRCP, FRCPath, Nicholas John Goulden, MD PhD MRCPath, Ajay Vora
Journal: Blood
Blood (2019) 134 (Supplement_1): 2579.
https://doi.org/10.1182/blood-2019-127223
Published: 2019
Journal Articles

Developmental DNA Methylation Subtype Predicts Progression to Treatment and Survival in High-Count Monoclonal B Lymphocytosis

Free
Brian Giacopelli, BS, Kari G. Chaffee, MS, Yue-zhong Wu, MSc, John C. Byrd, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Christopher C. Oakes, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3022.
https://doi.org/10.1182/blood-2019-123564
Published: 2019
Journal Articles

40% of Females with Mantle Cell Lymphoma Are Managed with Initial Observation: Results from the MCL Biobank Observational Study

Free
Rory McCulloch, FRCPath, MRCP, MBBS, Alexandra Smith, PhD, Brian Wainman, Wendy Ingram, Amelia Lewis, Matthew Hawkins, Nicola Crosbie, Andrew Pettitt, FRCPath, PhD, Simon Rule
Journal: Blood
Blood (2019) 134 (Supplement_1): 2821.
https://doi.org/10.1182/blood-2019-128340
Published: 2019
Journal Articles

Real World Population-Based Exploration of the Pathology Subtyping and Treatment-Modalities of Diffuse Large B-Cell Lymphoma in Belgium in Relation to Survival

Free
Willem Daneels, MD, Michael Rosskamp, PhD, Gilles Macq, PhD, Estabraq Ismael Saadoon, MD, Anke De Geyndt, PhD, Fritz Offner, MD, Helene A. Poirel, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2894.
https://doi.org/10.1182/blood-2019-122443
Published: 2019
Journal Articles

Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)

Free
Yan Leyfman, BS, Erel Joffe, MDMSc, Esther Drill, PhD, Sridevi Rajeeve, MD, Andrew D. Zelenetz, MD PhD, Maria Lia Lia Palomba, Craig H. Moskowitz, Carol S. Portlock, MD, Ariela Noy, MD, Steven M. Horwitz, MD, Alison J. Moskowitz, MD, Paul A. Hamlin, MD, Matthew J Matasar, MD, Anita Kumar, MD, Gottfried R. von Keudell, MD PhD, Connie Lee Batlevi, MD PhD, Anas Younes, MD, David J. Straus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2826.
https://doi.org/10.1182/blood-2019-123257
Published: 2019
Journal Articles

Systematic Investigation of Microenvironmental Drug Resistance Mechanisms in Chronic Lymphocytic Leukemia

Free
Peter-Martin Bruch, Holly Giles, BA, Carolin Kolb, Sophie Rabe, MSc, Tobias Roider, MD, Mareike Knoll, Mark Kriegsmann, MD, Katharina Kriegsmann, MD, Christiane Zgorzelski, Sebastian Scheinost, Lena Wagner, Carsten Müller-Tidow, MD, Thorsten Zenz, MD, Wolfgang Huber, PhD, Sascha Dietrich, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3363.
https://doi.org/10.1182/blood-2019-128392
Published: 2019